Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Gender Differences Seen in Adverse Drug Reactions
FRIDAY, April 26, 2019 (HealthDay News) — The risk for adverse drug reactions (ADRs) may be higher for women, even when accounting for gender differences in drug use, according to a study published online April 2 in the British Journal of Clinical Pharmacology.
Abstract/Full Text (subscription or payment may be required)
National Hand Hygiene Initiative Successful in Australia
FRIDAY, April 19, 2019 (HealthDay News) — The National Hand Hygiene Initiative (NHHI) has successfully sustained improvement in hand hygiene compliance, according to a study recently published in The Lancet Infectious Diseases and presented at the European Congress of Clinical Microbiology & Infectious Diseases, held from April 13 to 16 in Amsterdam.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
More Information
Loan Forgiveness, Educational Debt May Affect Practice Patterns
FRIDAY, April 19, 2019 (HealthDay News) — Increased educational debt appears to directly influence physician practice choice, according to a study published in the April issue of the Journal of the American Osteopathic Association.
Naltrexone Implant Helps HIV Patients Prevent Opioid Relapse
FRIDAY, April 19, 2019 (HealthDay News) — Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Sixty People Charged in Massive Opioid Painkiller Investigation
THURSDAY, April 18, 2019 (HealthDay News) — Fifty-three medical professionals, including 31 doctors, are among the 60 people charged by U.S. authorities for their alleged involvement in the illegal prescribing and distribution of opioid painkillers.
UB-421 Monotherapy Maintains HIV Viral Suppression
THURSDAY, April 18, 2019 (HealthDay News) — Monotherapy with UB-421 antibody, which blocks the HIV virus-binding site on human CD4+ T-cells, maintains viral suppression for up to 16 weeks in HIV-infected persons undergoing analytic treatment interruption, according to a study published in the April 18 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Standardizing Demographics Ups Accuracy of Patient Matching
MONDAY, April 15, 2019 (HealthDay News) — Standardizing demographic data can improve the accuracy of patient matching, according to a study published in the May issue of the Journal of the American Medical Informatics Association.
Abstract/Full Text (subscription or payment may be required)
Prevalence of Extragenital STDs High in Men Who Have Sex With Men
FRIDAY, April 12, 2019 (HealthDay News) — Extragenital (rectal and pharyngeal) chlamydia and gonorrhea are prevalent among men who have sex with men (MSM), according to research published in the April 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Domestic Responsibilities Tied to Physician Mothers’ Satisfaction
THURSDAY, April 11, 2019 (HealthDay News) — For physician mothers in procedural specialties, being responsible for five or more domestic tasks is associated with an increased likelihood of career dissatisfaction, according to a study published online April 10 in JAMA Surgery.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
STI Incidence Up After Receipt of HIV Preexposure Prophylaxis
WEDNESDAY, April 10, 2019 (HealthDay News) — For gay and bisexual men, receipt of HIV preexposure prophylaxis (PrEP) is associated with an increase in sexually transmitted infections (STIs), according to a study published in the April 9 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
First Two-Drug Regimen Approved for HIV-1 Treatment
MONDAY, April 8, 2019 (HealthDay News) — The U.S. Food and Drug Administration has announced the approval of Dovato (dolutegravir and lamivudine), the first approved two-drug, fixed-dose, complete regimen for adults with HIV-1 who have not been previously treated with antiretroviral medication.
Alcohol, Drug Misuse Tied to Long-Term Health Problems
MONDAY, April 8, 2019 (HealthDay News) — More than one-third of U.S. adults in recovery for alcohol and other drug (AOD) use have health problems related to previous substance use, according to a study published online March 16 in the Journal of Addiction Medicine.
Abstract/Full Text (subscription or payment may be required)
CDC: TB Incidence Declined Slightly in United States in 2017
MONDAY, April 8, 2019 (HealthDay News) — In 2017, tuberculosis (TB) incidence declined in the United States and modest progress was made toward global TB elimination, according to two studies published in the March 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Abstract/Full Text – Talwar
Abstract/Full Text – MacNeil
Depressive Symptoms May Up Risk for Death in HIV+ Veterans
FRIDAY, April 5, 2019 (HealthDay News) — Among U.S. veterans with HIV infection, depressive symptoms are associated with a significantly increased risk for mortality, but depression is not, according to a study published online March 29 in HIV Medicine.
Abstract/Full Text (subscription or payment may be required)
Americans Borrowed $88 Billion in Past Year to Pay for Health Care
TUESDAY, April 2, 2019 (HealthDay News) — About one in eight Americans borrowed a total of $88 billion in the past year to pay for health care, a new West Health-Gallup survey shows.
CNN Article
West Health-Gallup Survey
Dolutegravir Feasible for HIV Tx in Women of Childbearing Age
TUESDAY, April 2, 2019 (HealthDay News) — Dolutegravir should be considered for antiretroviral therapy (ART) in treating HIV in women of childbearing potential in resource-limited settings, despite its associated risk for neural tube defects, according to a study published online April 2 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Over-the-Counter Meds Save Health Care System Money
TUESDAY, April 2, 2019 (HealthDay News) — On average, each dollar spent on over-the-counter (OTC) medicines saves the U.S. health care system $7.20, totaling nearly $146 billion in annual savings, according to a report released March 18 by the Consumer Healthcare Products Association (CHPA).
Doctors Unclear on Legal Obligations in Caring for Patients With Disability
MONDAY, April 1, 2019 (HealthDay News) — Practicing physicians might not understand their legal responsibilities when caring for people with disability, which may contribute to inequalities in their care, according to a study published online April 1 in Health Affairs.
Abstract/Full Text (subscription or payment may be required)
Copyright © 2019 ScoutNews, LLC. All rights reserved.
